Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

(TSX: BCT )

1.160 +0.030 (+2.65%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 34,580
Open 1.140
Bid (Size) 1.130 (1)
Ask (Size) 1.160 (32)
Prev. Close 1.130
Today's Range 1.110 - 1.160
52wk Range 0.6400 - 8.000
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023
FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 13, 2023 – USA News Group – Sufferers of many different ailments saw reason to grow their hope in 2022 when the US Food... 
Via FinancialNewsMedia
Exposures Product Safety
BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire

Performance

YTD
-83.73%
-83.73%
1 Month
+70.59%
+70.59%
3 Month
-7.20%
-7.20%
6 Month
-60.94%
-60.94%
1 Year
-84.86%
-84.86%

More News

Read More
BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily
Via TheNewswire.com
BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily
Via NewMediaWire
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer
Via FinancialNewsMedia
BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
Via News Direct
Topics Death
Exposures Death
BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
Via TheNewswire.com
Topics Death
Exposures Death
BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
Via TheNewswire.com
Topics Stocks
Exposures Product Safety US Equities
BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
Via News Direct
Exposures Product Safety
IPA’s Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies
From ImmunoPrecise Antibodies
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.